Coronavirus – Impact on Valuing Investments in Private Debt and Equity

March 18, 2020 | (Online)
Webcast , Countries

As we approach the end of the first quarter of 2020, investment fund managers and investors in non-traded or infrequently traded debt and equity investments have a fiduciary duty to report independent and credible fair value information to investors and stakeholders. This process is complicated by the rapidly changing global health situation due to the coronavirus (COVID-19). Given the uncertainty demonstrated in the public markets and the unknown ultimate impact of COVID-19, using informed judgment to measure the fair value of investments will require even more thought and analysis.

Please join us for a discussion on how best to reflect the impact of COVID-19 on measuring and reporting fair value for the March 31, 2020 quarter end.

Register now.

Schedule: 12:00 p.m. - 1:00 p.m. (EDT)


  • What impact will COVID-19 have on fair value estimates at March 31, 2020?
  • How are market participants transacting in times of increased uncertainty?
  • How are value drivers impacted by the epidemic (revenue, cost, growth, competition, market conditions, etc.)? 
  • Should projections be updated and what is the impact on fair value if they have not been updated?
  • How much weight should be placed on observable market transactions and public market volatility?
  • What are the short, medium and long-term impacts of a market disruption on the business and operations of an investee company?


CPE credit will be provided.

Please submit your questions in advance of the webcast by sending a message to us at [email protected]

Valuation Advisory Services

Our valuation experts provide valuation services for financial reporting, tax, investment and risk management purposes.

Alternative Asset Advisory

Heightened regulatory concerns and vigilance, together with increased investor scrutiny, have led to increased demand for independent expert advice.

Portfolio Valuation

Kroll specializes in assisting clients with the valuation of alternative investments, specifically securities and positions for which there are no "active market" quotations.